Prometheus Biosciences contends that the current treatments for inflammatory bowel disease are inadequate, taking a “one-size-fits-all approach” that doesn’t account for biologic variation. The ...

Prometheus raised US$12 billion in funding from investors, including JPMorgan Chase & Co, Goldman Sachs Group Inc, BlackRock ...

The Technology Association of Iowa is pleased to announce the winners of the 2021 Prometheus Awards Presented by LWBJ. The Prometheus Awards were celebrated on Thursday in downtown Des Moines. The ...

Jeff Bezos's AI startup Prometheus raised $12B from JPMorgan, Goldman Sachs, and BlackRock at a $41B valuation. It's building an "artificial general engineer." ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...

The developers of the popular Prometheus monitoring tool announced a new operating mode for the software today that’s designed to run more efficiently in low-resource environments such as edge ...

Prometheus raised $12 billion from a heavyweight syndicate of investors, including JPMorgan Chase, Goldman Sachs Group, ...

Prometheus Biosciences, a Phase 1 biotech developing precision antibody therapies for IBD and related diseases, filed on Friday with the SEC to raise up to $125 million in an initial public offering.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Meet the winners in our 2021 Fast 50 Awards, highlighting ...

DevOps security startup Sysdig Inc. announced a raft of updates to its cloud monitoring platform today, saying they will help increase adoption of the open-source Prometheus tool that’s used to ...